Peak6 Investments LLC Roivant Sciences Ltd. Transaction History
Peak6 Investments LLC
- $43.5 Billion
- Q3 2024
A detailed history of Peak6 Investments LLC transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Peak6 Investments LLC holds 30,000 shares of ROIV stock, worth $381,000. This represents 0.0% of its overall portfolio holdings.
Number of Shares
30,000
Previous 29,999
-0.0%
Holding current value
$381,000
Previous $317,000
9.15%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding ROIV
# of Institutions
311Shares Held
508MCall Options Held
1.26MPut Options Held
2.52M-
Sb Investment Advisers (Uk) LTD London, X065.9MShares$837 Million6.27% of portfolio
-
Qvt Financial LP New York, NY65.8MShares$836 Million73.2% of portfolio
-
Viking Global Investors LP54.1MShares$687 Million2.42% of portfolio
-
Vanguard Group Inc Valley Forge, PA41.7MShares$529 Million0.01% of portfolio
-
Black Rock Inc. New York, NY35.4MShares$449 Million0.01% of portfolio
About Roivant Sciences Ltd.
- Ticker ROIV
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 704,382,976
- Market Cap $8.95B
- Description
- Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...